Back to School: How biopharma can reboot drug development. Access exclusive analysis here

BAY 43-9006: Phase II preliminary data

Preliminary data from an international Phase II trial in 137 patients showed that

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE